Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Clinical trial NCT03833921 · RECRUITING
Trial details
- NCT number
- NCT03833921
- Sponsor
- Martha Mims
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2028-11-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.